Clinical Trial Update: 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 4-aminopyridine, atenolol, or placebo in vestibular migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Vestibular Migraine

Drugs mentioned

• 4-aminopyridine (4-aminopyridine)
• Atenolol (Atenolol)

Snippet

Sponsor: Massachusetts Eye and Ear Infirmary | Conditions: Vestibular Migraine, Migraine Disorders | Phase 2 | Status: WITHDRAWN